Open AccessPhase I, Single-Dose, Dose-Escalating Study of Inhaled Dry Powder Capreomycin: a New Approach to Therapy of Drug-Resistant Tuberculosis
Author(s) -
Ashwin Dharmadhikari,
Mohan G. Kabadi,
Bob Gerety,
Anthony J. Hickey,
P. Bernard Fourie,
Edward A. Nardell
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/xtq2-2z49
Subject(s) - capreomycin , tuberculosis , drug , medicine , pharmacology , dry powder inhaler , mycobacterium tuberculosis , pathology , asthma , ethambutol , inhaler
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom